Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.060,25
-1,18%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cyclacel Pharmaceuticals Inc (CYCC) Cyclacel Pharmaceuticals Inc (CYCC) Notizie

Cyclacel Pharmaceuticals Inc

CYCC
0,333
0,002 (0,60%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/12/202422:05GLOBECyclacel Pharmaceuticals Announces Its Exploration of..
14/11/202422:15GLOBECyclacel Pharmaceuticals Announces Closing of Exercise of..
13/11/202418:22GLOBECyclacel Pharmaceuticals Announces Exercise of Warrants for..
12/11/202422:45GLOBECyclacel Pharmaceuticals Reports Third Quarter Financial..
24/10/202415:15GLOBECyclacel Pharmaceuticals Announces That Nasdaq Granted an..
23/10/202415:15GLOBECyclacel Pharmaceuticals Reports New Clinical Data from..
09/10/202415:15GLOBECyclacel Pharmaceuticals to Present New Clinical Data From..
25/9/202415:15GLOBECyclacel Pharmaceuticals Announces Completion of Enrollment..
04/9/202415:15GLOBECyclacel Pharmaceuticals Announces Participation at the H.C...
03/9/202415:15GLOBECyclacel Pharmaceuticals Confirms It Has Filed an Appeal to..
14/8/202422:05GLOBECyclacel Pharmaceuticals Reports Second Quarter Financial..
07/8/202415:15GLOBECyclacel Pharmaceuticals to Release Second Quarter 2024..
26/6/202415:15GLOBECyclacel Announces Notice of Intention to Grant New European..
04/6/202414:00GLOBECyclacel’s Fadraciclib Demonstrates Efficacy in..
03/6/202414:00GLOBECyclacel Pharmaceuticals Reports New Clinical Data at 2024..
14/5/202422:05GLOBECyclacel Pharmaceuticals Reports First Quarter Financial..
08/5/202415:15GLOBECyclacel Pharmaceuticals to Release First Quarter 2024..
02/5/202422:30GLOBECyclacel Pharmaceuticals Announces Closing of $8.0 Million..
30/4/202419:51APS$8 Million Private Placement Announcement Sends Biotech..
30/4/202413:00GLOBECyclacel Pharmaceuticals Announces $8.0 Million Private..
01/4/202415:15GLOBECyclacel Pharmaceuticals to Present New Clinical Data at..
19/3/202421:05GLOBECyclacel Pharmaceuticals Reports Fourth Quarter and Full..
19/3/202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
13/3/202421:05GLOBECyclacel Pharmaceuticals to Release Fourth Quarter and Full..
07/3/202415:15GLOBECyclacel Pharmaceuticals Announces Preclinical..
06/3/202415:15GLOBECyclacel Pharmaceuticals Announces Receipt of $2.9 Million..
20/2/202415:15GLOBECyclacel Pharmaceuticals to Participate in 2024 BIO CEO &..
30/1/202415:15GLOBECyclacel Pharmaceuticals Announces the Appointment of Brian..
Apertura: 0,339 Min: 0,3251 Max: 0,35
Chiusura: 0,331

La tua Cronologia

NASDAQ
CYCC
Cyclacel Pharmaceuticals
ASI
FTSE
FTSE ATHEX Large Cap
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network